Indeed, OTUB2 deficiency significantly enhanced the production of TNF‐α, a detrimental cytokine underlying mucosal damage in IBD, in mucosa‐infiltrating macrophages after DSS treatment (Figure S3). Here, OTUB2 is linked to inflammatory bowel disease.